Louise Collins

1.0k total citations
31 papers, 805 citations indexed

About

Louise Collins is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Louise Collins has authored 31 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cellular and Molecular Neuroscience, 14 papers in Molecular Biology and 14 papers in Neurology. Recurrent topics in Louise Collins's work include Parkinson's Disease Mechanisms and Treatments (13 papers), Nuclear Receptors and Signaling (9 papers) and Nerve injury and regeneration (8 papers). Louise Collins is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (13 papers), Nuclear Receptors and Signaling (9 papers) and Nerve injury and regeneration (8 papers). Louise Collins collaborates with scholars based in Ireland, United Kingdom and Italy. Louise Collins's co-authors include André Toulouse, Yvonne M. Nolan, Gerard W. O’Keeffe, Thomas J. Connor, Aideen M. Sullivan, Séan Wyatt, Alan G. Jones, J. Spratt, Valerie A. Jackson and Anna Avdeeva and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Geophysical Research Atmospheres and Journal of Neurochemistry.

In The Last Decade

Louise Collins

29 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Louise Collins Ireland 15 303 253 229 173 80 31 805
Wataru Satake Japan 15 303 1.0× 236 0.9× 364 1.6× 97 0.6× 23 0.3× 45 721
Henrik Bengtsson Sweden 16 544 1.8× 530 2.1× 148 0.6× 100 0.6× 7 0.1× 22 1.1k
Susanna Carboni Italy 19 503 1.7× 813 3.2× 157 0.7× 64 0.4× 12 0.1× 35 1.3k
Andrea Mancini Italy 20 209 0.7× 190 0.8× 258 1.1× 292 1.7× 4 0.1× 52 979
Yanming Xu China 19 278 0.9× 269 1.1× 698 3.0× 223 1.3× 9 0.1× 95 1.1k
Owen Jones United Kingdom 16 187 0.6× 355 1.4× 29 0.1× 188 1.1× 11 0.1× 39 979
C. Romera Spain 10 166 0.5× 150 0.6× 26 0.1× 147 0.8× 154 1.9× 13 544
Shintaro Hayashi Japan 27 708 2.3× 935 3.7× 1.3k 5.8× 433 2.5× 163 2.0× 110 2.5k
Shinya Tasaki United States 18 399 1.3× 52 0.2× 33 0.1× 91 0.5× 34 0.4× 52 974
Jong‐Heon Kim South Korea 24 641 2.1× 298 1.2× 375 1.6× 819 4.7× 9 0.1× 90 2.1k

Countries citing papers authored by Louise Collins

Since Specialization
Citations

This map shows the geographic impact of Louise Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise Collins more than expected).

Fields of papers citing papers by Louise Collins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louise Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise Collins. The network helps show where Louise Collins may publish in the future.

Co-authorship network of co-authors of Louise Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Louise Collins. A scholar is included among the top collaborators of Louise Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise Collins. Louise Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Morris, Alex, Caitriona M. Guinane, Séan Wyatt, et al.. (2025). The class-IIa HDAC inhibitor TMP269 promotes BMP-Smad signalling and is neuroprotective in in vitro and in vivo 6-hydroxydopamine models of Parkinson's disease. Neuropharmacology. 268. 110319–110319. 3 indexed citations
3.
Pemberton, John, Louise Collins, Renuka Dias, et al.. (2024). Enhancing equity in access to automated insulin delivery systems in an ethnically and socioeconomically diverse group of children with type 1 diabetes. BMJ Open Diabetes Research & Care. 12(3). e004045–e004045. 4 indexed citations
4.
5.
Sullivan, Aideen M., et al.. (2021). Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson’s disease. Neural Regeneration Research. 17(1). 38–38. 4 indexed citations
6.
7.
Tuboly, Eszter, Gerard M. Moloney, Cathal McCarthy, et al.. (2021). NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson’s Disease. Molecular Neurobiology. 59(1). 61–76. 8 indexed citations
8.
Wyatt, Séan, et al.. (2020). STRAP and NME1 Mediate the Neurite Growth-Promoting Effects of the Neurotrophic Factor GDF5. iScience. 23(9). 101457–101457. 13 indexed citations
9.
Collins, Louise, et al.. (2020). The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease. Neural Regeneration Research. 15(8). 1432–1432. 23 indexed citations
10.
Lebedev, Sergei, Daniel Farrell, David L. Stalling, et al.. (2019). Education and public engagement using an active research project: lessons and recipes from the SEA-SEIS North Atlantic Expedition's programme for Irish schools. SHILAP Revista de lepidopterología. 2(2). 143–155. 2 indexed citations
11.
Wyatt, Séan, Daniela Mercatelli, Michele Morari, et al.. (2019). Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein Signaling. Frontiers in Cell and Developmental Biology. 7. 191–191. 17 indexed citations
12.
13.
Collins, Louise, Jimena Monzón‐Sandoval, Aideen M. Sullivan, et al.. (2015). Nociceptin/Orphanin FQ Inhibits the Survival and Axon Growth of Midbrain Dopaminergic Neurons Through a p38-MAPK Dependent Mechanism. Molecular Neurobiology. 53(10). 7284–7297. 9 indexed citations
14.
Collins, Louise, Eric J. Downer, André Toulouse, & Yvonne M. Nolan. (2014). Mitogen-Activated Protein Kinase Phosphatase (MKP)-1 in Nervous System Development and Disease. Molecular Neurobiology. 51(3). 1158–1167. 30 indexed citations
15.
Hegarty, Shane V., Louise Collins, Sarah L. Roche, et al.. (2014). Canonical BMP–Smad Signalling Promotes Neurite Growth in Rat Midbrain Dopaminergic Neurons. NeuroMolecular Medicine. 16(2). 473–489. 41 indexed citations
16.
Collins, Louise, et al.. (2014). Class-IIa Histone Deacetylase Inhibition Promotes the Growth of Neural Processes and Protects Them Against Neurotoxic Insult. Molecular Neurobiology. 51(3). 1432–1442. 32 indexed citations
17.
Collins, Louise, Aideen M. Sullivan, Séan Wyatt, et al.. (2014). Expression of endogenous Mkp1 in 6-OHDA rat models of Parkinson’s disease. SpringerPlus. 3(1). 205–205. 3 indexed citations
18.
Collins, Louise, Gerard W. O’Keeffe, Caitríona M. Long-Smith, et al.. (2013). Mitogen-Activated Protein Kinase Phosphatase (MKP)-1 as a Neuroprotective Agent: Promotion of the Morphological Development of Midbrain Dopaminergic Neurons. NeuroMolecular Medicine. 15(2). 435–446. 27 indexed citations
19.
Collins, Louise, André Toulouse, Thomas J. Connor, & Yvonne M. Nolan. (2012). Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease. Neuropharmacology. 62(7). 2154–2168. 238 indexed citations
20.
Crampton, Sean J., Louise Collins, André Toulouse, Yvonne M. Nolan, & Gerard W. O’Keeffe. (2011). Exposure of foetal neural progenitor cells to IL‐1β impairs their proliferation and alters their differentiation – a role for maternal inflammation?. Journal of Neurochemistry. 120(6). 964–973. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wataru Satake Breakdown of academic impact, for papers by Henrik Bengtsson Breakdown of academic impact, for papers by Susanna Carboni Breakdown of academic impact, for papers by Andrea Mancini Breakdown of academic impact, for papers by Yanming Xu Breakdown of academic impact, for papers by Owen Jones Breakdown of academic impact, for papers by C. Romera Breakdown of academic impact, for papers by Shintaro Hayashi Breakdown of academic impact, for papers by Shinya Tasaki Breakdown of academic impact, for papers by Jong‐Heon Kim
Rankless by CCL
2026